DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $186,000 | -13.5% | 3,669 | +33.6% | 0.01% | 0.0% |
| Q2 2021 | $215,000 | +54.7% | 2,747 | +12.5% | 0.01% | +42.9% |
| Q1 2021 | $139,000 | +58.0% | 2,441 | +0.6% | 0.01% | +16.7% |
| Q3 2020 | $88,000 | +576.9% | 2,426 | +420.6% | 0.01% | +500.0% |
| Q2 2020 | $13,000 | -50.0% | 466 | -69.2% | 0.00% | -50.0% |
| Q1 2020 | $26,000 | +271.4% | 1,513 | +375.8% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | -22.2% | 318 | -19.9% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |